Three Good Things 2020: a Brief Text-based Wellness Intervention

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT04676698
Collaborator
(none)
223
1
2
6.8
32.9

Study Details

Study Description

Brief Summary

This trial will be open to all Michigan Medicine Department of Family Medicine faculty, resident, or staff.

The intervention will consist of asking participants the "3 Good Things" based on positive psychology theory. Participants will be asked to list three things that went well that day and to consider their role in these outcomes. Pre and post surveys will be completed to evaluate this intervention.

At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Three Good Things
  • Behavioral: Wait list control arm and then Three Good Things
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
223 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Three Good Things 2020: a Brief Text-based Wellness Intervention
Actual Study Start Date :
Feb 3, 2021
Actual Primary Completion Date :
Aug 28, 2021
Actual Study Completion Date :
Aug 28, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Three Good Things

Three times weekly for three weeks, participants will receive a text-based survey asking them to type or dictate "three good things."

Behavioral: Three Good Things
The treatment phase will last 3 weeks. However, participants will complete surveys at baseline and up to 6 months. At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.

Active Comparator: Waitlist Control Arm then Three Good Things

Participants will have surveys in the waiting period for 3 months and then be crossed over to the treatment arm Three Good Things.

Behavioral: Wait list control arm and then Three Good Things
Surveys will be completed for 3 months prior to treatment and then after treatment.

Outcome Measures

Primary Outcome Measures

  1. Change in the Positive and Negative Affect Schedule (PANAS-SF) between the intervention and control group [Pre-Treatment (baseline), up to 6 months]

    This is a 10 item survey to measure positive and negative affect. Responses include; very slightly or not at all, a little, quite a bit, and extremely. Higher scores of Positive Affect (PA) subscale represent higher positive affect higher scores of Negative affect (NA) subscale represent higher negative affect.

Secondary Outcome Measures

  1. Change in self-reported physical health [Pre-Treatment (baseline), up to 6 months]

    This is a 1 question item to assess participants physical health ( 1=Excellent 2=good 3=fair 4=poor).

  2. Change in self-reported mental health [Pre-Treatment (baseline), up to 6 months]

    This is a 1 question item to assess participants mental health ( 1=Excellent 2=good 3=fair 4=poor).

  3. Change in Gratitude using the Gratitude Adjective Checklist (GAC) [Pre-Treatment (baseline), up to 6 months]

    The GAC is a 3-item self-report measure of state gratitude in which participants select, (1) A little (2) Moderately, Quite a bit (4), and Extremely (5).The total score on GAC ranges from 3 to 15, with higher score indicating greater state gratitude.

  4. Change in depression using the Patient Health Questionnaire 9-item (PHQ-9) score [Pre-Treatment (baseline) to 6 months]

    PHQ-9 scores reflect depression severity. Participants will select responses that include 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Ranges in scores are from 0-27 (Scores: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe).

  5. Change in Satisfaction with Life Questionnaire [Pre-Treatment (baseline), up to 6 months]

    This is a 5 question questionnaire in which participants select from 7 responses that are given a 1-7 scale from strongly disagree to strongly agree. Scoring ranges from 5-35 where 20 = neutral (the higher the score the more satisfaction).

  6. Change in the Hope Scale [Pre-Treatment (baseline), up to 6 months]

    This is a 12 item questionnaire in which participants select from answers that include 1=definitely false 2=mostly false 3=mostly true 4=definitely true. Scores range from 12-48 with higher scores indicating greater hope.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Faculty, resident, or staff in the Michigan Medicine (MM) Department of Family Medicine
Exclusion Criteria:
  • Not a member of Family Medicine at MM

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Katherine Gold, MD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Katherine Gold, Associate Professor of Family Medicine and Associate Professor of Obstetrics and Gynecology, University of Michigan
ClinicalTrials.gov Identifier:
NCT04676698
Other Study ID Numbers:
  • HUM00188399
First Posted:
Dec 21, 2020
Last Update Posted:
Dec 3, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Katherine Gold, Associate Professor of Family Medicine and Associate Professor of Obstetrics and Gynecology, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 3, 2021